Availability and acceptability of medical abortion in Nepal: Health care providers' perspectives

被引:16
作者
Tamang, A [1 ]
Tamang, J [1 ]
机构
[1] CREHPA, Kathmandu, Nepal
关键词
abortifacient drugs; medical abortion; mifepristone; misoprostol; providers' perspectives; chemists; Nepal;
D O I
10.1016/S0968-8080(05)26194-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Abortion was legalised in Nepal in September 2002 and manual vacuum aspiration is the main procedure used for safe abortion. Although medical abortion has not yet officially been introduced in Nepal, with the highly porous Indo-Nepal border and the easy availability of mifepristone and misoprostrol in Indian chemists' shops, it is possible the drugs ore entering from Indian markets illegally. This study aimed to gouge current awareness of the availability of medical abortion drugs in Nepal and explore what health professionals and paramedics felt about the use of medical abortion to expand access to safe abortion in the country. Data were drawn from interviews with private obstetrician-gynaecologists, general physicians, paramedics, ayurvedic and homeopathic practitioners and chemists in 24 urban municipalities and peri-urban areas in Nepal. Various types of allopathic and indigenous forms of medicine for menstrual regulation in the Nepalese market were widely known whereas knowledge of the availability of mifepristone and misoprostrol was low. Almost all respondents had a positive view of the potential for providing mifepristone and misoprostol in Nepal and most thought that obstetrician-gynaecologists, general physicians and other certified abortion care providers should be able to provide the drugs. Many respondents were interested in doing so themselves. Registration of mifepristone and misoprostrol is the key to introducing medical abortion in Nepal and should happen as soon as possible. (c) 2005 Reproductive Health Matters. All rights reserved.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 15 条
[1]   Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India [J].
Coyaji, K ;
Elul, B ;
Krishna, U ;
Otiv, S ;
Ambardekar, S ;
Bopardikar, A ;
Raote, V ;
Ellertson, C ;
Winikoff, B .
CONTRACEPTION, 2002, 66 (01) :33-40
[2]  
*CREHPA, 2002, UND CULT SPEC PREGN
[3]  
*CTR RES ENV HLTH, 2000, MAN AB REL COMPL HOS
[4]  
*CTRR RES ENV HLTH, 2000, WOM PRIS NEP AB STUD
[5]  
*GYN HLTH PROJ, 2004, PROV MED AB DEV COUN
[6]  
*MIN HLTH, 1998, MAT MORT MORB STUD
[7]  
*MIN HLTH, 2003, SAF AB SERV PROC
[8]  
Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20
[9]   Induced septic abortion: A major factor in maternal mortality and morbidity [J].
Rana, A ;
Pradhan, N ;
Gurung, G ;
Singh, M .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2004, 30 (01) :3-8
[10]   Abortion law reform in Nepal: Women's right to life and health [J].
Shakya, G ;
Kishore, S ;
Bird, C ;
Barak, J .
REPRODUCTIVE HEALTH MATTERS, 2004, 12 (24) :75-84